Loading...
Market
Will Triton increase its stake in Evotec to over 15% by January 31, 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Regulatory filings or official statements from Triton
Story
Evotec Shares Surge 13.3% as Triton Considers Takeover with Near 10% Stake
Nov 11, 2024, 11:00 AM
Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed that private equity firm Triton had built an over 9% stake in the German drug development company. Triton Partners is considering a takeover bid for Evotec, following its emergence as one of the drug developer’s largest shareholders. Triton has become the biggest shareholder with a near 10% stake.
View original story
Similar markets
Roche • 25%
Novartis • 25%
Sanofi • 25%
No counteroffer • 25%
Increase by 0-5% • 25%
Increase by 5-10% • 25%
Increase by 10-15% • 25%
Increase by more than 15% • 25%
Successful acquisition at €11 per share • 25%
Acquisition at a different price • 25%
Acquisition fails • 25%
Acquisition postponed • 25%
Yes • 50%
No • 50%
Support the acquisition • 25%
Oppose the acquisition • 25%
Neutral stance • 25%
Unclear or mixed reactions • 25%
